Publicaciones en colaboración con investigadores/as de McMaster University (29)

2024

  1. Assessment of a fast challenge test with iodinated contrast media in allergic patients with anaphylaxis

    Allergo Journal International

2023

  1. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

2022

  1. Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection

    European Respiratory Journal, Vol. 60, Núm. 2

  2. Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection

    PLoS Pathogens, Vol. 18, Núm. 5

2021

  1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

    Clinical and Translational Allergy, Vol. 11, Núm. 4

  2. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

  3. Interrupting reactivation of immunologic memory diverts the allergic response and prevents anaphylaxis

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 4, pp. 1381-1392

  4. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

  5. Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate

    Frontiers in Immunology, Vol. 12

2020

  1. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

  4. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 10, pp. 2445-2476

  5. Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity

    Frontiers in Immunology, Vol. 11

2019

  1. IgG1 + B-cell immunity predates IgE responses in epicutaneous sensitization to foods

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 1, pp. 165-175

  2. Human BCR analysis of single-sorted, putative IgE+ memory B cells in food allergy

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 336-339.e6

  3. IL-17 Production by γδ+ T Cells Is Critical for Inducing Th17 Responses in the Female Genital Tract and Regulated by Estradiol and Microbiota

    ImmunoHorizons, Vol. 3, Núm. 7, pp. 317-330

  4. Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity

    PLoS ONE, Vol. 14, Núm. 6

  5. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Allergy: European Journal of Allergy and Clinical Immunology

2018

  1. The IgE memory reservoir in food allergy

    Journal of Allergy and Clinical Immunology